Emergent BioSolutions (EBS) Return on Capital Employed (2011 - 2026)
Emergent BioSolutions (EBS) posted quarterly Return on Capital Employed of 5.18% for Q1 2026, up 1279.0% year-over-year from 0.38% in Q1 2025, and down 34.86% quarter-over-quarter from 7.96% in Q4 2025.
Emergent BioSolutions (EBS) Return on Capital Employed (2011 - 2026) Analysis & Trends
Emergent BioSolutions' Return on Capital Employed history runs 16 years deep, the most recent figure standing at 5.18% for Q1 2026.
- In Q1 2026, Return on Capital Employed rose 1279.0% year-over-year to 5.18%; the TTM figure through Mar 2026 stood at 5.18% (up 1279.0% YoY), while the FY2025 annual figure was 8.19%, up 1572.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 5.18%, down from 7.96% in the prior quarter.
- The five-year high for Return on Capital Employed was 9.78% in Q1 2022, with the low at 60.19% in Q4 2023.
- The 5-year median for Return on Capital Employed is 8.55% (2024), against an average of 13.66%.
- The sharpest annual moves came in 2023 and 2024: Return on Capital Employed plunged 6053 bps in 2023, then surged 5164 bps in 2024.
- Emergent BioSolutions' Return on Capital Employed stood at 9.43% in 2022, then slumped by 538 bps to 60.19% in 2023, then soared by 86 bps to 8.55% in 2024, then soared by 193 bps to 7.96% in 2025, then sank by 35 bps to 5.18% in 2026.
- Business Quant data shows EBS's Return on Capital Employed at 5.18% in Q1 2026, 7.96% in Q4 2025, and 9.1% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 6.60% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 17.16% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 6.07% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 22.04% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -0.29% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 18.67% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 5.52% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Emergent BioSolutions | 251.81 Mn | 110.91 Mn | 137.20 Mn | -6.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.02% |
| Mar 31, 2026 | 5.18% |
| Dec 31, 2025 | 7.96% |
| Sep 30, 2025 | 9.10% |
| Jun 30, 2025 | 8.23% |
| Mar 31, 2025 | -7.61% |
| Dec 31, 2024 | -8.55% |
| Sep 30, 2024 | -11.30% |
| Jun 30, 2024 | -43.28% |
| Mar 31, 2024 | -45.55% |
| Dec 31, 2023 | -60.19% |
| Sep 30, 2023 | -53.78% |
| Jun 30, 2023 | -28.92% |
| Mar 31, 2023 | -17.61% |
| Dec 31, 2022 | -9.43% |
| Sep 30, 2022 | 6.75% |
| Jun 30, 2022 | 6.96% |
| Mar 31, 2022 | 9.78% |
| Dec 31, 2021 | 13.45% |
| Sep 30, 2021 | 12.38% |